The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The Large And Small-Scale Bioprocessing Market Compare Between 2026 And 2030?
The large and small-scale bioprocessing market has experienced substantial growth in recent years. Projections indicate it will expand from $67.66 billion in 2025 to $76.73 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. Historically, this expansion has been driven by factors such as the increase in biopharmaceutical manufacturing, heightened investment in biotechnology research and development, the broadening of fermentation-based production, the growing adoption of cell culture technologies, and advancements in large-scale stainless steel bioreactors.
The large and small-scale bioprocessing market is projected to undergo significant expansion in the coming years. By 2030, this market is forecasted to achieve a value of $119.99 billion, growing at a compound annual growth rate (CAGR) of 11.8%. This anticipated growth during the forecast period is primarily driven by the escalating demand for biologics and biosimilars, the increasing embrace of single-use technologies, the progression of personalized and precision medicine, the broadening of CDMO services, and a heightened emphasis on sustainable bioprocessing methodologies. Noteworthy trends expected in this period include the wider acceptance of single-use and modular bioprocessing systems, the increasing requirement for flexible small-scale bioprocessing in research and development, the expansion of contract biomanufacturing and outsourcing models, a stronger focus on achieving process scalability from laboratory to commercial production, and the growing integration of upstream and downstream bioprocess workflows.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
What Market Drivers Are Helping Shape The Large And Small-Scale Bioprocessing Market Expansion?
The increasing need for biologics is anticipated to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics are defined as therapeutic items originating from living organisms or their constituent parts, encompassing vaccines, blood and its constituents, gene treatments, tissues, and recombinant therapeutic proteins. This rising demand for biologics stems from progress in biotechnology, improved comprehension of disease mechanisms, and the requirement for targeted and individualized treatments. Both large-scale and small-scale bioprocessing play crucial roles in the successful development and commercialization of biologics. Small-scale bioprocessing is vital for the initial phases of development, optimization processes, and feasibility assessments. Conversely, large-scale bioprocessing guarantees the efficient, consistent production of biologics, adhering to regulatory standards for their commercial distribution. As an example, in February 2024, data from the National Library of Medicine, a US-based medical library, indicated that in 2023, the Food and Drug Administration (FDA) sanctioned 55 new drugs, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), which represented a 50% surge from the 37 approvals in 2022. Consequently, the increasing need for biologics is a primary factor driving the expansion of the large and small-scale bioprocessing market.
Which Segment Groups Define The Large And Small-Scale Bioprocessing Market Landscape?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
What Trends Are Affecting The Growth Of The Large And Small-Scale Bioprocessing Market?
Companies within the large and small-scale bioprocessing market are concentrating on creating novel solutions, including fixed-bed, low-footprint bioreactor controllers. This effort aims to satisfy the increasing need for high-productivity, cost-effective, and scalable viral vector and advanced therapy production, which is propelled by the rapid growth in gene therapies, vaccines, and biologics. Such a controller represents a dedicated hardware unit designed to manage extensive cell culture in fixed-bed reactors, providing a compact design, a user-friendly interface, and streamlined fluid management, unlike conventional large-scale stirred-tank bioreactors which require considerable physical space, substantial capital investment, and intricate infrastructure. As an illustration, Univercells Technologies SA, a bioprocessing firm based in Belgium, introduced the scale-X Nitro Controller in May 2025. This device is specifically engineered to operate their 200 m² and 600 m² scale-X Nitro fixed-bed bioreactors. The controller itself is a compact, wheeled unit with a 1.6 m² footprint, capable of passing through standard cleanroom doorways. It accommodates both adherent and suspension cultures and provides highly intuitive operational control. It facilitates quick scale-up from research and development to commercial production, achieving this in approximately 8 months, concurrently lowering the cost-of-goods by 36–82% when contrasted with conventional adherent processes. Through its combination of high productivity and a simplified, space-saving design, the scale-X Nitro Controller assists biomanufacturers, particularly CDMOs and vaccine developers, in expediting their development schedules and decreasing the financial hurdles for large-scale viral production.
Which Companies Form The Competitive Landscape Of The Large And Small-Scale Bioprocessing Market?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim
Access The Complete Large And Small-Scale Bioprocessing Market Report:
Which Region Holds The Largest Share In The Large And Small-Scale Bioprocessing Market?
North America was the largest region in the large and small-scale bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Large And Small-Scale Bioprocessing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
Browse Through More Reports Similar to the Global Large And Small-Scale Bioprocessing Market 2026, By The Business Research Company
Single Use Bioprocessing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report
Bioprocessing Technology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report
Bioprocess Technology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioprocess-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model